Mariana Arruda
Mariana Arruda is an endocrinologist and the medical director at Novo Nordisk, a pharmaceutical company known for developing diabetes and obesity medications, including semaglutide. She has been actively involved in clinical research regarding the potential of semaglutide in treating Alzheimer's disease, particularly focusing on its effects in early stages of cognitive impairment.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Brazil:
Mariana Arruda discusses the expectations for semaglutide in treating Alzheimer's and its potential regulatory implications.
8